2025 Financial Highlights

The Group faced a challenging year in 2025, as demand in our traditional ATE market declined significantly due to cautious customer spending. This downturn impacted our operational performance for FYE2025. Nevertheless, we remain proactive in pursuing opportunities aligned with our strengths. During the year, we engaged a new customer to develop an innovative test solution for metalens technology, while also continue focusing on the medical device market.